MWC 2025: Amdocs Opens GenAI-Focused Experience Lab in North America, Showcasing Leading-Edge Generative AI Capabilities that Fuel Business Growth
Amdocs (NASDAQ:DOX) has expanded its Experience Lab in Dallas, Texas, with a renewed focus on generative AI (GenAI). The enhanced facility showcases production-proven GenAI capabilities and features collaborations with leading tech companies including Amazon Web Services, Dell, Microsoft, NVIDIA, and OpenAI.
The lab serves as an innovation hub, incorporating Amdocs' R&D centers from Israel and India, and houses the Open GenAI Lab Incubator for enterprises and startups. Recent trials demonstrated significant improvements, including a 63% reduction in average handling time using Amdocs amAIz-powered care agent.
Key features include:
- Customer care and technical support digital humans using NVIDIA NeMo and Amazon SageMaker
- Enterprise operations optimization with Microsoft Azure OpenAI Service
- Network operations with NVIDIA Omniverse platform
- AI Factory featuring Amdocs amAIz and Dell Technologies infrastructure
Amdocs (NASDAQ:DOX) ha ampliato il suo Experience Lab a Dallas, Texas, con un rinnovato focus su AI generativa (GenAI). La struttura potenziata mette in mostra capacità di GenAI già testate in produzione e presenta collaborazioni con importanti aziende tecnologiche tra cui Amazon Web Services, Dell, Microsoft, NVIDIA e OpenAI.
Il laboratorio funge da hub di innovazione, incorporando i centri di R&S di Amdocs in Israele e India, e ospita l'Open GenAI Lab Incubator per imprese e startup. Le prove recenti hanno dimostrato miglioramenti significativi, tra cui una riduzione del 63% del tempo medio di gestione grazie all'agente di assistenza potenziato da Amdocs amAIz.
Le caratteristiche principali includono:
- Umani digitali per assistenza clienti e supporto tecnico utilizzando NVIDIA NeMo e Amazon SageMaker
- Ottimizzazione delle operazioni aziendali con Microsoft Azure OpenAI Service
- Operazioni di rete con la piattaforma NVIDIA Omniverse
- AI Factory con infrastruttura Amdocs amAIz e Dell Technologies
Amdocs (NASDAQ:DOX) ha ampliado su Experience Lab en Dallas, Texas, con un renovado enfoque en IA generativa (GenAI). La instalación mejorada muestra capacidades de GenAI probadas en producción y cuenta con colaboraciones con importantes empresas tecnológicas, incluyendo Amazon Web Services, Dell, Microsoft, NVIDIA y OpenAI.
El laboratorio sirve como un centro de innovación, incorporando los centros de I+D de Amdocs en Israel e India, y alberga el Open GenAI Lab Incubator para empresas y startups. Las pruebas recientes demostraron mejoras significativas, incluyendo una reducción del 63% en el tiempo promedio de manejo utilizando el agente de atención potenciado por Amdocs amAIz.
Las características clave incluyen:
- Humanos digitales para atención al cliente y soporte técnico utilizando NVIDIA NeMo y Amazon SageMaker
- Optimización de operaciones empresariales con Microsoft Azure OpenAI Service
- Operaciones de red con la plataforma NVIDIA Omniverse
- AI Factory con infraestructura de Amdocs amAIz y Dell Technologies
Amdocs (NASDAQ:DOX)는 텍사스 댈러스에 있는 Experience Lab을 확장하고 생성 AI(GenAI)에 대한 새로운 집중을 하고 있습니다. 향상된 시설은 생산에서 입증된 GenAI 기능을 선보이며 Amazon Web Services, Dell, Microsoft, NVIDIA 및 OpenAI와 같은 주요 기술 회사와의 협업을 특징으로 합니다.
이 실험실은 혁신 허브 역할을 하며, 이스라엘과 인도의 Amdocs R&D 센터를 통합하고 기업 및 스타트업을 위한 Open GenAI Lab Incubator를 포함하고 있습니다. 최근 시험에서는 Amdocs amAIz 기반의 케어 에이전트를 사용하여 평균 처리 시간을 63% 단축하는 등의 중요한 개선 사항이 입증되었습니다.
주요 기능은 다음과 같습니다:
- NVIDIA NeMo와 Amazon SageMaker를 사용하는 고객 지원 및 기술 지원 디지털 휴먼
- Microsoft Azure OpenAI Service를 통한 기업 운영 최적화
- NVIDIA Omniverse 플랫폼을 통한 네트워크 운영
- Amdocs amAIz 및 Dell Technologies 인프라를 특징으로 하는 AI Factory
Amdocs (NASDAQ:DOX) a élargi son Experience Lab à Dallas, Texas, avec un nouvel accent sur l'IA générative (GenAI). L'installation améliorée met en avant des capacités de GenAI éprouvées en production et présente des collaborations avec des entreprises technologiques de premier plan, dont Amazon Web Services, Dell, Microsoft, NVIDIA et OpenAI.
Le laboratoire sert de centre d'innovation, intégrant les centres de R&D d'Amdocs en Israël et en Inde, et abrite l'Open GenAI Lab Incubator pour les entreprises et les startups. Des essais récents ont démontré des améliorations significatives, notamment une réduction de 63 % du temps moyen de traitement grâce à l'agent de support alimenté par Amdocs amAIz.
Les caractéristiques clés incluent :
- Humains numériques pour le service client et le support technique utilisant NVIDIA NeMo et Amazon SageMaker
- Optimisation des opérations d'entreprise avec le Microsoft Azure OpenAI Service
- Opérations réseau avec la plateforme NVIDIA Omniverse
- AI Factory avec l'infrastructure Amdocs amAIz et Dell Technologies
Amdocs (NASDAQ:DOX) hat sein Experience Lab in Dallas, Texas, erweitert und legt einen erneuten Schwerpunkt auf generative KI (GenAI). Die verbesserte Einrichtung zeigt bewährte GenAI-Fähigkeiten und umfasst Kooperationen mit führenden Technologieunternehmen wie Amazon Web Services, Dell, Microsoft, NVIDIA und OpenAI.
Das Labor dient als Innovationszentrum und integriert die F&E-Zentren von Amdocs in Israel und Indien und beherbergt den Open GenAI Lab Incubator für Unternehmen und Startups. Jüngste Tests zeigten signifikante Verbesserungen, darunter eine Reduzierung der durchschnittlichen Bearbeitungszeit um 63 % mit dem von Amdocs amAIz unterstützten Service-Agenten.
Zu den wichtigsten Funktionen gehören:
- Kundenservice und technischer Support durch digitale Menschen mit NVIDIA NeMo und Amazon SageMaker
- Optimierung der Unternehmensabläufe mit Microsoft Azure OpenAI Service
- Netzwerkoperationen mit der NVIDIA Omniverse-Plattform
- AI Factory mit Amdocs amAIz und Dell Technologies Infrastruktur
- 63% improvement in average handling time through amAIz-powered care agent
- Expanded facility and partnerships with major tech companies
- New revenue opportunities through AI Factory and Marketplace monetization
- None.
The newly expanded facility brings to life next-generation customer experiences, and features solutions from leading technology companies including Amazon Web Services, Dell, Microsoft, NVIDIA, and OpenAI
JERSEY CITY, NJ / ACCESS Newswire / February 28, 2025 / Amdocs (NASDAQ:DOX), a leading provider of software and services to communications and media companies, today announced the expansion and evolution of the Amdocs Experience Lab, its cutting-edge innovation facility located in Dallas, Texas. The new lab emerges with a larger physical footprint, AI-centric hardware and infrastructure, and an evolved focus on generative AI (GenAI), serving as an innovation catalyst for emerging GenAI capabilities.
As one of the first telecom-focused labs to showcase production-proven GenAI capabilities, the Amdocs Experience Lab draws on the Amdocs group's R&D innovation centers in Israel and India and brings together the entire suite of Amdocs' AI and GenAI products and services to showcase tangible, scalable GenAI-powered experiences that span the entire telco lifecycle, from infrastructure to customer care. Additionally, the lab serves as the home of Amdocs' Open GenAI Lab Incubator, where enterprises, startups and partners alike are able to trial new capabilities in a cohort model, leveraging the best of Amdocs and advanced partner technology in one place. As generative AI evolves to agentic AI, collaboration environments such as the Experience Lab will be the place to create future AI agents for telecom networks.
According to a recent study [1], improving customer experience and increasing operating efficiency are two of the top three business priorities for service providers globally. GenAI is uniquely positioned to address both of these imperatives, and visitors to the Amdocs Experience Lab will see firsthand how customers are achieving meaningful results toward this goal. This includes a recent customer trial of the Amdocs amAIz-powered care agent that led to dramatic improvements in the experience of their customers by, for example, improving average handling time (AHT) by nearly
Visitors can experience the latest GenAI advancements powered by Amdocs amAIz and Amdocs' rich ecosystem of GenAI partners. These advancements include:
Customer care, sales and technical support digital humans, built using NVIDIA NeMo and Amazon SageMaker
Enterprise ordering and operations optimization, featuring Microsoft Azure OpenAI Service
Customer interaction & agent assistance, featuring Google's Customer Engagement Suite
Network digital twin and operations, built with the NVIDIA Omniverse platform
AI Factory including Amdocs amAIz, Marketplace & Monetization for NVIDIA accelerated computing platforms and AI services, powered by Dell Technologies' Servers (w/ GPUs) and Infrastructure Automation Suite
ORAN network automation & pre-staging, based on NVIDIA NIM microservices
"The Amdocs Experience Lab is a physical manifestation of our commitment to technology-enabled innovation, and a reflection of the reality that GenAI is fundamentally changing the way we live and work," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "We've built a collaborative space that not only highlights the transformative power of our GenAI platforms but also brings to life how Amdocs and our partners are driving new possibilities for our customers in an increasingly AI-first world, while taking advantage of Dallas' important role in global technology innovation."
1 OMDIA's IT Enterprise Insights: Telecom 2025 Report
Supporting Resources
Learn more about Amdocs Experience Lab
Keep up with Amdocs news by visiting the company's website
About Amdocs
Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers' innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and large enterprise customers. Our employees around the globe are here to accelerate service providers' migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of
Amdocs' Forward-Looking Statement
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macro-economic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other global or regional events or pandemics, as well as the current inflationary environment, and the effects of these conditions on the company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the company's customers, Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the company's offerings and operations and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2024 filed on December 17, 2024 and our Form 6-K furnished for the first quarter of fiscal 2025 on February 18, 2025.
Media Contacts
Michael Zema
Amdocs Public Relations
mzema@amdocs.com
Emily Holt
PAN Communications for Amdocs
amdocs@pancomm.com
SOURCE: Amdocs Management Limited
View the original press release on ACCESS Newswire
FAQ
What improvements did Amdocs DOX Experience Lab achieve in customer handling time?
Which major tech companies are partnering with Amdocs DOX in the new Experience Lab?
What are the main GenAI capabilities offered at Amdocs DOX Experience Lab?
Where is the new Amdocs DOX GenAI Experience Lab located?
How does Amdocs DOX Experience Lab connect with other R&D centers?
